Charles Darwin University

CDU eSpace
Institutional Repository

 
CDU Staff and Student only
 

Melioidosis: Epidemiology, pathophysiology, and management

Cheng, Allen C. and Currie, Bart J. (2005). Melioidosis: Epidemiology, pathophysiology, and management. Clinical Microbiology Reviews,18(2):383-416.

Document type: Journal Article
Citation counts: Altmetric Score Altmetric Score is 26
Google Scholar Search Google Scholar

Title Melioidosis: Epidemiology, pathophysiology, and management
Author Cheng, Allen C.
Currie, Bart J.
Journal Name Clinical Microbiology Reviews
Publication Date 2005
Volume Number 18
Issue Number 2
ISSN 0893-8512   (check CDU catalogue open catalogue search in new window)
Start Page 383
End Page 416
Total Pages 34
Place of Publication US
Publisher American Society For Microbiology
HERDC Category C1 - Journal Article (DEST)
Abstract Melioidosis, caused by the gram-negative saprophyte Burkholderia pseudomallei, is a disease of public health importance in southeast Asia and northern Australia that is associated with high case-fatality rates in animals and humans. It has the potential for epidemic spread to areas where it is not endemic, and sporadic case reports elsewhere in the world suggest that as-yet-unrecognized foci of infection may exist. Environmental determinants of this infection, apart from a close association with rainfall, are yet to be elucidated. The sequencing of the genome of a strain of B. pseudomallei has recently been completed and will help in the further identification of virulence factors. The presence of specific risk factors for infection, such as diabetes, suggests that functional neutrophil defects are important in the pathogenesis of melioidosis; other studies have defined virulence factors (including a type III secretion system) that allow evasion of killing mechanisms by phagocytes. There is a possible role for cell-mediated immunity, but repeated environmental exposure does not elicit protective humoral or cellular immunity. A vaccine is under development, but economic constraints may make vaccination an unrealistic option for many regions of endemicity. Disease manifestations are protean, and no inexpensive, practical, and accurate rapid diagnostic tests are commercially available; diagnosis relies on culture of the organism. Despite the introduction of ceftazidime- and carbapenem-based intravenous treatments, melioidosis is still associated with a significant mortality attributable to severe sepsis and its complications. A long course of oral eradication therapy is required to prevent relapse. Studies exploring the role of preventative measures, earlier clinical identification, and better management of severe sepsis are required to reduce the burden of this disease.
Keywords Epidemiology
melioidosis
pathophysiology
DOI http://dx.doi.org/10.1128/CMR.18.2.383-416.2005   (check subscription with CDU E-Gateway service for CDU Staff and Students  check subscription with CDU E-Gateway in new window)
Description for Link Link to Article
URL http://cmr.asm.org/cgi/reprint/18/2/383?maxtoshow=&hits=10&RESULTFORMAT=&fulltext=Melioidosis%3A+Epidemiology%2C+pathophysiology%2C+and+management+&searchid=1&FIRSTINDEX=0&resourcetype=HWCIT
 
Versions
Version Filter Type
Access Statistics: 44 Abstract Views  -  Detailed Statistics
Created: Mon, 26 Nov 2007, 15:07:47 CST